TriSalus Life Sciences (TLSI) Retained Earnings (2020 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Retained Earnings of -$329.0 million for Q1 2026, down 13.5% year-over-year from -$380.4 million in Q1 2025, and little changed quarter-over-quarter from -$330.6 million in Q4 2025.
TriSalus Life Sciences (TLSI) Retained Earnings (2020 - 2026) Analysis & Trends
TriSalus Life Sciences' Retained Earnings history runs 7 years deep, the most recent figure standing at -$329.0 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 13.5% year-over-year to -$329.0 million; the TTM figure through Mar 2026 stood at -$329.0 million (down 13.5% YoY), while the FY2025 annual figure was -$330.6 million, down 18.26% from the prior year.
- Retained Earnings for Q1 2026 stood at -$329.0 million, roughly flat from -$330.6 million in the prior quarter.
- The five-year high for Retained Earnings was $294.2 million in Q3 2025, with the low at -$330.6 million in Q4 2025.
- The 5-year median for Retained Earnings is -$186.4 million (2022), against an average of -$107.2 million.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings jumped 1998.41% in 2023, then sank 1658.71% in 2024.
- TriSalus Life Sciences' Retained Earnings stood at -$186.4 million in 2022, then sank by 33.88% to -$249.5 million in 2023, then slipped by 12.04% to -$279.5 million in 2024, then fell by 18.26% to -$330.6 million in 2025, then climbed by 0.47% to -$329.0 million in 2026.
- Business Quant data shows TLSI's Retained Earnings at -$329.0 million in Q1 2026, -$330.6 million in Q4 2025, and $294.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.15 Bn |
| 10 | TriSalus Life Sciences | 306.64 Mn | 260.35 Mn | 9.90 Mn | 344.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 344.78 Mn |
| Mar 31, 2026 | -329.04 Mn |
| Dec 31, 2025 | -330.58 Mn |
| Sep 30, 2025 | 294.24 Mn |
| Jun 30, 2025 | -298.21 Mn |
| Mar 31, 2025 | -289.90 Mn |
| Dec 31, 2024 | -279.55 Mn |
| Sep 30, 2024 | -269.44 Mn |
| Jun 30, 2024 | -265.93 Mn |
| Mar 31, 2024 | 226.67 Mn |
| Dec 31, 2023 | -249.50 Mn |
| Sep 30, 2023 | 221.35 Mn |
| Jun 30, 2023 | -15.12 Mn |
| Mar 31, 2023 | -13.86 Mn |
| Dec 31, 2022 | -186.36 Mn |
| Sep 30, 2022 | -11.66 Mn |
| Jun 30, 2022 | -11.54 Mn |
| Mar 31, 2022 | -13.88 Mn |
| Dec 31, 2021 | -16.72 Mn |
| Sep 30, 2021 | -19.61 Mn |